9-127710688-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001012502.3(CFAP157):āc.521A>Gā(p.Lys174Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000127 in 1,577,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001012502.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP157 | NM_001012502.3 | c.521A>G | p.Lys174Arg | missense_variant | 3/9 | ENST00000373295.7 | NP_001012520.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP157 | ENST00000373295.7 | c.521A>G | p.Lys174Arg | missense_variant | 3/9 | 5 | NM_001012502.3 | ENSP00000362392.1 | ||
PTRH1 | ENST00000335223.5 | c.205+4747T>C | intron_variant | 1 | ENSP00000493136.1 | |||||
CFAP157 | ENST00000614677.1 | c.521A>G | p.Lys174Arg | missense_variant | 3/9 | 2 | ENSP00000478313.1 | |||
CFAP157 | ENST00000496009.5 | n.484A>G | non_coding_transcript_exon_variant | 3/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 3AN: 188128Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 100922
GnomAD4 exome AF: 0.00000772 AC: 11AN: 1425424Hom.: 0 Cov.: 31 AF XY: 0.00000425 AC XY: 3AN XY: 705464
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.521A>G (p.K174R) alteration is located in exon 3 (coding exon 3) of the CFAP157 gene. This alteration results from a A to G substitution at nucleotide position 521, causing the lysine (K) at amino acid position 174 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at